HomeHealth CareBiotechnology

Biotechnology

Biotechnology

TriMed Reaches End Stage In Deal with Henry Schein

Howard Fine -
Biotechnology

Brent Reinke and the 101 Biotech Corridor

Howard Fine -
Biotechnology

Skin in the Game

Howard Fine -
Biotechnology

Amgen Creates New Therapy Line

Howard Fine -
Biotechnology

Cannabis-Centric DNA Test Lands U.S. Patent

Howard Fine -
Biotechnology

A2 Biotherapeutics Starts ‘Tmod’ Drug Clinical Trials

Howard Fine -
Biotechnology

Could FTC Amgen Lawsuit Have Ripple Effect?

SHERRY KARABIN -
Biotechnology

Two Labs Debut in West San Fernando Valley

Howard Fine -
Biotechnology

Acelyrin, Now Public, Focuses on Drug Pipeline

Howard Fine -
Biotechnology

FTC Moves to Quash Amgen Deal

Howard Fine -
Biotechnology

Acelyrin Raises $540M IPO; Shares Close Up 30% on First Day of Trading

Howard Fine -
Biotechnology

Fewer, But Larger, Local Bioscience Funding Deals

Howard Fine -
Biotechnology

Arcutis Drug Is with FDA for Approval

Howard Fine -
Biotechnology

Amgen to Lay Off 450, Citing Inflation, Prices

Howard Fine -
Biotechnology

Local Leaders

Howard Fine -
Biotechnology

A Woman of Substance

Howard Fine -
Biotechnology

PBS Biotech Raises $22 Million

Antonio Pequeño IV -
Biotechnology

Dantari Raises $47M in Round

ANTONIO PEQUEÑO IV -
Biotechnology

Amgen to Acquire Horizon Therapeutics in $27.8 Billion Deal

Antonio Pequeño IV -
Biotechnology

Med Firm Gets Grant

Antonio Pequeño IV -
Biotechnology

Atara Biotherapeutics Reports Inducement Grant

Antonio Pequeño IV -
Biotechnology

Amgen Research and Development Facility Opens in Bay Area

ANTONIO PEQUEÑO IV -
Biotechnology

Acelyrin Raises $300M to Further Growth

Gina Hall -
Biotechnology

Arcutis Buys British Drug Developer

Mark Madler -
Sign Up for Daily E-News Updates
Join Our Membership
Latest Articles